Amy Lansky | |
---|---|
Academic background | |
Alma mater | Swarthmore College University of North Carolina at Chapel Hill |
Academic work | |
Institutions | Office of National AIDS Policy National Center for HIV/AIDS,Viral Hepatitis,STD,and TB Prevention |
Amy Lansky is an American academic. She was the director of the Office of National AIDS Policy.
Lansky earned a bachelor's degree in political science from Swarthmore College. She holds doctoral and master's degrees in public health from the University of North Carolina at Chapel Hill. [1]
Lansky served as the Deputy Director for Surveillance,Epidemiology,and Laboratory Science in Centers for Disease Control and Prevention’s Division of HIV/AIDS Prevention where she provided scientific direction and oversight for HIV surveillance activities,epidemiologic studies and clinical trials,and laboratory research. Lansky was a Senior Policy Advisor to the Office of National Drug Control Policy and Office of National AIDS Policy where she ensured coordination on issues of substance abuse and HIV infection,and co-authored the National HIV/AIDS Strategy:Updated to 2020. She later became the director of the Office of National AIDS Policy. [1]
The Centers for Disease Control and Prevention (CDC) is the national public health agency of the United States. It is a United States federal agency under the Department of Health and Human Services,and is headquartered in Atlanta,Georgia.
The AIDS epidemic,caused by HIV,found its way to the United States between the 1970s and 1980s,but was first noticed after doctors discovered clusters of Kaposi's sarcoma and pneumocystis pneumonia in homosexual men in Los Angeles,New York City,and San Francisco in 1981. Treatment of HIV/AIDS is primarily via the use of multiple antiretroviral drugs,and education programs to help people avoid infection.
The United States President's Emergency Plan For AIDS Relief (PEPFAR) is a United States governmental initiative to address the global HIV/AIDS epidemic and help save the lives of those suffering from the disease. Launched by U.S. President George W. Bush in 2003,as of May 2020,PEPFAR has provided about $90 billion in cumulative funding for HIV/AIDS treatment,prevention,and research since its inception,making it the largest global health program focused on a single disease in history until the COVID-19 pandemic. PEPFAR is implemented by a combination of U.S. government agencies in over 50 countries and overseen by the Global AIDS Coordinator at the United States Department of State. As of 2023,PEPFAR has saved over 25 million lives,primarily in sub-Saharan Africa.
The National Center for HIV/AIDS,Viral Hepatitis,STD,and TB Prevention (NCHHSTP),formerly the National Center for HIV,STD,and TB Prevention (NCHSTP) is a part of the Centers for Disease Control and Prevention and is responsible for public health surveillance,prevention research,and programs to prevent and control human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS),other sexually transmitted diseases (STDs),viral hepatitis,and tuberculosis (TB). Center staff work in collaboration with governmental and nongovernmental partners at community,State,national,and international levels,applying well-integrated multidisciplinary programs of research,surveillance,technical assistance,and evaluation.
HIV/AIDS in China can be traced to an initial outbreak of the human immunodeficiency virus (HIV) first recognized in 1989 among injecting drug users along China's southern border. Figures from the Chinese Center for Disease Control and Prevention,World Health Organization,and UNAIDS estimate that there were 1.25 million people living with HIV/AIDS in China at the end of 2018,with 135,000 new infections from 2017. The reported incidence of HIV/AIDS in China is relatively low,but the Chinese government anticipates that the number of individuals infected annually will continue to increase.
The Office of National AIDS Policy,established under President Clinton in 1993,coordinates the continuing domestic efforts to implement the President's National HIV/AIDS Strategy. In addition,the office works to coordinate an increasingly integrated approach to the prevention,care and treatment of HIV/AIDS. As a unit of the Domestic Policy Council,the Office of National AIDS Policy coordinates with other White House offices. It is led by a director,who is appointed by the president.
{{Use American English{date=February 2022}}
HIV/AIDS in Jamaica has a 1.5 percent prevalence of the adult population estimated to be HIV-positive. There has been no significant change over the last five years and therefore Jamaica appears to have stabilized its HIV/AIDS epidemic.
With 1.28 percent of the adult population estimated by UNAIDS to be HIV-positive in 2006,Papua New Guinea has one of the most serious HIV/AIDS epidemics in the Asia-Pacific subregion. Although this new prevalence rate is significantly lower than the 2005 UNAIDS estimate of 1.8 percent,it is considered to reflect improvements in surveillance rather than a shrinking epidemic. Papua New Guinea accounts for 70 percent of the subregion's HIV cases and is the fourth country after Thailand,Cambodia,and Burma to be classified as having a generalized HIV epidemic.
Jeffrey S. Crowley is best known as a member of the Domestic Policy Council in the administration of U.S. President Barack Obama as the director of the Office of National AIDS Policy (ONAP) from 2009 to 2011,tasked with coordinating the U.S. government's efforts regarding HIV/AIDS prevention,treatment and care and developing the National HIV/AIDS Strategy.
Agnes Binagwaho is a Rwandan Politian,pediatrician,co-founder and the former vice chancellor of the University of Global Health Equity (2017-2022). In 1996,she returned to Rwanda where she provided clinical care in the public sector as well as held many positions including the position of Permanent Secretary for the Ministry of Health of Rwanda from October 2008 until May 2011 and Minister of Health from May 2011 until July 2016. She has been a professor of global health delivery practice since 2016 and a professor of pediatrics since 2017 at the University of Global Health Equity. She has served the health sector in various high-level government positions. She resides in Kigali.
Safiatou Thiam is a Senegalese public health doctor,a specialist in HIV/AIDS and former Minister of Health and Disease Prevention in the government of Cheikh Hadjibou Soumaré.She later became Executive Secretary of CNLS National Council against AIDS
Professor Kevin Andrew Fenton,is a Public Health Physician and Infectious Disease Epidemiologist. He is the London Regional Director at Office for Health Improvement and Disparities,Regional Public Health Director at NHS London and the Statutory Health Advisor to the Mayor of London,Sadiq Khan. He is the current President of the United Kingdom Faculty of Public Health and holds Honourable Professorships with the University College London and London School of Hygiene and Tropical Medicine.
Mary Jane Rotheram-Borus is a licensed clinical psychologist and professor with the University of California,Los Angeles,Department of Psychiatry and Biobehavioral Sciences. Rotheram is the professor-in-residence in the Semel Institute for Neuroscience and Human Behavior. She is the Director of the Global Center for Children and Families at UCLA and the former director of the Center for HIV Identification,Prevention,and Treatment Services.
Dr. Debrework Zewdie,former director of the World Bank Global AIDS Program and Deputy Executive Director and COO of the Global Fund,is an Ethiopian national who has led strategy,policy implementation,and management of development programs at country,regional,and global levels for international bodies such as the World Bank and The Global Fund to Fight AIDS,Tuberculosis and Malaria. As an immunologist,she conceptualized and managed the groundbreaking US$1 billion Multi-country HIV/AIDS Program that changed the AIDS funding landscape and pioneered the large-scale multi-sectorial response with direct financing to civil society and the private sector. Dr. Zewdie led the articulation of the World Bank's first global strategy on HIV/AIDS and the Global HIV/AIDS Program of Action. As a founding UNAIDS Global Coordinator,she has been instrumental in making the unique cooperative structure of the UNAIDS family a working reality,fostering strong inter-agency partnerships. She is an advocate for women's health and was a founding vice president and member of the Society for Women and AIDS in Africa (SWAA). She established institutional rigor at the Global Fund and led its wide-ranging internal reform which culminated in the ongoing corporate transformation program. Dr. Zewdie has a Ph.D. in clinical immunology from the University of London,a postdoctoral fellowship at SYVA Company,and was a Senior MacArthur Fellow at the Harvard Center for Population and Development Studies. Dr. Zewdie was a Richard L. and Ronay A. Menschel Senior Leadership Fellow at the Harvard T.H. Chan School of Public Health in 2015. During her Fellowship at the Harvard Chan School,she also participated as a speaker on Voices in Leadership,an original webcast series,in a discussion titled,"Leadership in Getting AIDS on the World Bank Agenda",moderated by Dr. Barry Bloom.
Thomas J. Coates is the Director of the multi-campus University of California Global Health Institute,a UC-wide initiative established to improve health and reduce the burden of disease throughout the world. He is Professor Emeritus at the UCLA David Geffen School of Medicine and Founding Director of the UCLA Center for World Health,a joint initiative of the David Geffen School of Medicine at UCLA and UCLA Health,He has conducted extensive research in the realm of HIV and is the Michael and Sue Steinberg Endowed Professor of Global AIDS Research within the Division of Infectious Diseases at UCLA and Distinguished Professor of Medicine. Health-related behavior is of particular interest to Coates. Throughout his career as a health expert,his theory-based research has been focused on interventions aimed at reducing risks and threats to health
Maureen Goodenow is an American scientist and Professor of Pathology,Immunology,and Laboratory Medicine. She is best known for her work on HIV/AIDS research and advocacy.
Cynthia Ann Gómez is an American psychologist who works in public health. She is known for her work in the field of HIV/AIDS prevention,health care access and health equity for minority individuals and committees. Likewise,one of her most major accomplishments was being the founding director of the Health Equity Institute at San Francisco State University. She has been a teacher and researcher,as well as a leader in both teaching and governmental positions.
John N. Nkengasong is a Cameroonian-American virologist serving as the Global AIDS Coordinator in the Biden administration since 2022 and Senior Bureau Official for Global Health Security and Diplomacy since 2023. He previously worked as the Director of the Africa Centres for Disease Control and Prevention from 2016 to 2022,as well as at the World Health Organization (WHO) and Centers for Disease Control and Prevention. During the COVID-19 pandemic,Nkengasong was appointed the WHO Special Envoy for Africa.
Sandra Thurman is known for her work on AIDS. She was appointed in 1997 as the first director of the Office of National AIDS Policy serving in Bill Clinton's administration. As of 2023 she is the senior advisor to the Division of Global HIV and Tuberculosis at the Centers for Disease Control and Prevention and Chief Strategy Officer at the Office of the Global AIDS Coordinator,which leads the implementation of PEPFAR,and Global Health Diplomacy at the U.S. Department of State. She is also a Professor of Practice at the Rollins School of Public Health at Emory University.
This article incorporates public domain material from websites or documents of the United States government .